Piperacillin Sodium,Tazobactam Sodium - Drug Shortage Information

Public shortage context is available across 9 visible exact NDC pages for this generic family.

This family page is organized from FDA/openFDA shortage records and other publicly available source material, then indexed by generic drug name, manufacturer, NDC, and package details for faster browsing.

Family summary

Historical shortage references are available across related Piperacillin Sodium,Tazobactam Sodium presentations from multiple manufacturers.

  • 0 current shortage context pages.
  • 9 historical shortage context pages.
  • 2 manufacturers represented.

Related research paths

Common brands and presentations in this family

These exact presentation links are useful for brand-name, size, and NDC-specific searches related to this shortage family.

Exact NDC product pages in this shortage family

Use the exact NDC page when your team needs package-level product details, public shortage references, and the strongest route into RFQ and sourcing workflows. These links open directly to the Drug Shortage Information section for each product page.

Drug NameNDC 11ManufacturerShortage Context
Piperacillin Sodium,Tazobactam Sodium 3 g / 15mL; 0.375 g / 15mL Injection 15 mL (Piperacillin and Tazobactam)
NDC 63323-0300-30 | 10 Vial | Fresenius Kabi USA, LLC
63323-0300-30Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 3 g / 15mL; 0.375 g / 15mL Injection 15 mL (Piperacillin and Tazobactam)
NDC 63323-0300-36 | 10 Vial | Fresenius Kabi USA, LLC
63323-0300-36Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 2 g / 10mL; 0.25 g / 10mL Injection 10 mL (Piperacillin and Tazobactam)
NDC 63323-0309-20 | 10 Vial | Fresenius Kabi USA, LLC
63323-0309-20Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 2 g / 10mL; 0.25 g / 10mL Injection 10 mL (Piperacillin and Tazobactam)
NDC 63323-0309-26 | 10 Vial | Fresenius Kabi USA, LLC
63323-0309-26Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 4 g / 20mL; 0.5 g / 20mL Injection 20 mL (Piperacillin and Tazobactam)
NDC 63323-0320-50 | 10 Vial | Fresenius Kabi USA, LLC
63323-0320-50Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 4 g / 20mL; 0.5 g / 20mL Injection 20 mL (Piperacillin and Tazobactam)
NDC 63323-0320-56 | 10 Vial | Fresenius Kabi USA, LLC
63323-0320-56Fresenius Kabi USA, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 2 g / 1; 0.25 g / 1 Injection 10 Vial (Piperacillin and Tazobactam)
NDC 44567-0801-10 | 10 Vial | WG Critical Care, LLC
44567-0801-10WG Critical Care, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 3 g / 1; 0.375 g / 1 Injection 10 Vial (Piperacillin and Tazobactam)
NDC 44567-0802-10 | 10 Vial | WG Critical Care, LLC
44567-0802-10WG Critical Care, LLCHistorical shortage context
Piperacillin Sodium,Tazobactam Sodium 4 g / 1; 0.5 g / 1 Injection 10 Vial (Piperacillin and Tazobactam)
NDC 44567-0803-10 | 10 Vial | WG Critical Care, LLC
44567-0803-10WG Critical Care, LLCHistorical shortage context

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.